Jiangsu Lanfeng Bio-chemical Co.,Ltd

SZSE:002513.SZ

6.68 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 1,741.6281,445.241,443.9321,341.9711,504.4351,481.3921,850.6411,456.6891,010.4161,252.0621,372.0771,268.551,143.273914.109627.543908.081550.598
Cost of Revenue 1,777.3241,435.8111,448.6611,157.7931,170.2671,120.881,287.2967.161806.9821,109.521,141.7351,009.233899.044711.778462.546712.917451.564
Gross Profit -35.6969.429-4.729184.178334.168360.512563.441489.528203.434142.542230.342259.317244.229202.332164.997195.16499.034
Gross Profit Ratio -0.020.007-0.0030.1370.2220.2430.3040.3360.2010.1140.1680.2040.2140.2210.2630.2150.18
Reseach & Development Expenses 15.25611.65112.91715.88934.83745.26457.65744.88321.81723.56639.52830.21610.8253.5282.43.8881.804
General & Administrative Expenses 93.84642.25972.01259.686104.211174.28484.08954.32986.0215.99924.04224.424.49518.22911.52711.7521.602
Selling & Marketing Expenses 25.21413.56311.53561.031111.437151.202164.925146.63959.47651.04953.60759.21755.2546.50525.37730.74620.184
SG&A 119.0655.82283.547120.717215.649325.486249.015200.967145.49667.04877.64983.61779.74564.73536.90442.49921.785
Other Expenses -7.66151.80872.25259.85159.1997.55272.48917.8226.18217.3545.535-0.5899.3761.60924.09414.6423.983
Operating Expenses 182.292119.282168.716196.457309.675468.301379.16323.954234.125147.182154.74149.094120.28297.36363.08172.52139.098
Operating Income -346.672-109.853-531.80926.60823.362-107.23145.159105.549-94.882-61.87319.21369.37498.9489.08893.144103.80842.548
Operating Income Ratio -0.199-0.076-0.3680.020.016-0.0720.0780.072-0.094-0.0490.0140.0550.0870.0970.1480.1140.077
Total Other Income Expenses Net -136.346-137.116-7.051-23.837-583.181-814.394-88.88-43.575-58.086-39.941-52.075-41.599-26.364-14.27214.822-5.106-13.434
Income Before Tax -354.333-246.969-538.862.77-559.819-921.62356.279121.998-88.777-44.58123.52768.62497.58390.697116.738117.53746.502
Income Before Tax Ratio -0.203-0.171-0.3730.002-0.372-0.6220.030.084-0.088-0.0360.0170.0540.0850.0990.1860.1290.084
Income Tax Expense -6.59773.724-47.668-12.053-43.264-46.67220.83214.818-20.008-7.1162.6029.39314.11813.87517.83119.71116.403
Net Income -332.26-320.693-491.19214.824-516.555-874.95135.447107.181-68.77-37.46421.10259.23183.46576.82198.90697.82630.099
Net Income Ratio -0.191-0.222-0.340.011-0.343-0.5910.0190.074-0.068-0.030.0150.0470.0730.0840.1580.1080.055
EPS -0.89-0.94-1.440.044-1.52-2.570.10.32-0.32-0.180.10.280.390.470.630.620.19
EPS Diluted -0.89-0.94-1.440.044-1.52-2.570.10.32-0.32-0.180.10.280.390.470.630.620.19
EBITDA -96.303-71.472-68.506150.482166.2551.858293.719328.393111.629170.839199.997175.43185.842137.216149.918160.70376.518
EBITDA Ratio -0.055-0.049-0.0470.1120.1110.0350.1590.2250.110.1360.1460.1380.1630.150.2390.1770.139